{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:46:13Z","timestamp":1792586773315,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI074321"],"award-info":[{"award-number":["U19 AI074321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037304"],"award-info":[{"award-number":["1037304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1058685"],"award-info":[{"award-number":["1058685"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132975"],"award-info":[{"award-number":["1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154265"],"award-info":[{"award-number":["1154265"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["LBSM-109\/IF-14"],"award-info":[{"award-number":["LBSM-109\/IF-14"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.celrep.2020.01.099","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T10:57:39Z","timestamp":1582628259000},"page":"2512-2525.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis"],"prefix":"10.1016","volume":"30","author":[{"given":"Rajiv","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth Sankar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Montes de Oca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"De Labastida Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bhushan","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Faleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teija C.M.","family":"Frame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meru","family":"Sheel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey.R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Corvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambross","family":"Koufariotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Mukhopadhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Nylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Uzonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R.","family":"Engwerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2020.01.099_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2020.01.099_bib2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2020.01.099_bib3","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","article-title":"IL-27 and IL-21 are associated with T\u00a0cell IL-10 responses in human visceral leishmaniasis","volume":"186","author":"Ansari","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib4","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood-2014-01-547760","article-title":"Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms","volume":"123","author":"Bhagwat","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2020.01.099_bib5","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI119798","article-title":"Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice","volume":"100","author":"Boring","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2020.01.099_bib6","first-page":"119","article-title":"Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice","volume":"30","author":"Bradley","year":"1977","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib7","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2020.01.099_bib8","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.4049\/jimmunol.1300768","article-title":"Tissue requirements for establishing long-term CD4+ T\u00a0cell-mediated immunity following Leishmania donovani infection","volume":"192","author":"Bunn","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib9","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.4049\/jimmunol.1701582","article-title":"Distinct Roles for CD4+ Foxp3+ Regulatory T Cells and IL-10-Mediated Immunoregulatory Mechanisms during Experimental Visceral Leishmaniasis Caused by Leishmania donovani","volume":"201","author":"Bunn","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2020.01.099_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection","volume":"13","author":"Butler","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-3024.2009.01167.x","article-title":"Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection","volume":"32","author":"Buxbaum","year":"2010","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20062648","article-title":"Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen","volume":"204","author":"Caton","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/infdis\/jiz074","article-title":"Interleukin 2 is an upstream regulator of CD4+ T\u00a0cells from visceral leishmaniasis patients with therapeutic potential","volume":"220","author":"Chauhan","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib15","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/IAI.01176-10","article-title":"Type I interferons increase host susceptibility to Trypanosoma cruzi infection","volume":"79","author":"Chessler","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2020.01.099_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res."},{"key":"10.1016\/j.celrep.2020.01.099_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/1756-0500-5-552","article-title":"Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report","volume":"5","author":"Colomba","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.celrep.2020.01.099_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.celrep.2020.01.099_bib19","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","article-title":"RNA-SeQC: RNA-seq metrics for quality control and process optimization","volume":"28","author":"DeLuca","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2020.01.099_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2020.01.099_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fimmu.2017.01633","article-title":"Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences","volume":"8","author":"Donovan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/jiy281","article-title":"Early Changes in CD4+ T-Cell Activation During Blood-Stage Plasmodium falciparum Infection","volume":"218","author":"Edwards","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.celrep.2020.01.099_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)64199-5","article-title":"A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection","volume":"161","author":"Engwerda","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2020.01.099_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2014.00498","article-title":"The Regulation of CD4(+) T\u00a0Cell Responses during Protozoan Infections","volume":"5","author":"Engwerda","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib27","doi-asserted-by":"crossref","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.6","article-title":"Interferons and viral infections","volume":"35","author":"Fensterl","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.celrep.2020.01.099_bib29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib30","doi-asserted-by":"crossref","first-page":"e1042","DOI":"10.1371\/journal.pntd.0001042","article-title":"Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study","volume":"5","author":"Gidwani","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N","article-title":"Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection","volume":"28","author":"Gorak","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib33","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/eji.201141539","article-title":"Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection","volume":"41","author":"Haque","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib34","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1172\/JCI70698","article-title":"Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity","volume":"124","author":"Haque","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2020.01.099_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/226168a0","article-title":"Effects of interferon inducers on the intracellular growth of the protozoan parasite, Leishmania donovani","volume":"226","author":"Herman","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2020.01.099_bib37","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/leu.2014.104","article-title":"Disseminated tuberculosis associated with ruxolitinib","volume":"28","author":"Hopman","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2020.01.099_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2020.01.099_bib39","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.0802860","article-title":"IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis","volume":"182","author":"Khouri","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib41","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","article-title":"Leishmania specific CD4 T\u00a0cells release IFN\u03b3 that limits parasite replication in patients with visceral leishmaniasis","volume":"8","author":"Kumar","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib42","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fimmu.2017.01492","article-title":"Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awy105","article-title":"JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis","volume":"141","author":"Ladislau","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2020.01.099_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.celrep.2020.01.099_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1\u03b2 production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"Lima-Junior","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib46","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.181.7.4908","article-title":"Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes","volume":"181","author":"Lopez","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/IAI.00643-07","article-title":"Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection","volume":"76","author":"Maroof","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2020.01.099_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"key":"10.1016\/j.celrep.2020.01.099_bib49","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.4049\/jimmunol.172.12.7574","article-title":"Protection against progressive leishmaniasis by IFN-beta","volume":"172","author":"Mattner","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2020.01.099_bib52","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","article-title":"Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages","volume":"193","author":"McNab","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2020.01.099_bib54","doi-asserted-by":"crossref","first-page":"e1005398","DOI":"10.1371\/journal.ppat.1005398","article-title":"Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology","volume":"12","author":"Montes de Oca","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2020.01.099_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.celrep.2016.09.015","article-title":"Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection","volume":"17","author":"Montes de Oca","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2020.01.099_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1601340","article-title":"T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection","volume":"199","author":"Moreira-Teixeira","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib57","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: Foe and occasionally friend","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib58","doi-asserted-by":"crossref","first-page":"310ra167","DOI":"10.1126\/scitranslmed.aac5477","article-title":"Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T\u00a0cells","volume":"7","author":"Mou","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib59","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib60","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.148.6.1858","article-title":"Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T\u00a0cell and lymphokine roles in initial versus established immunity","volume":"148","author":"Murray","year":"1992","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T\u00a0cells distinct from CD4+CD25+ (Foxp3) regulatory T\u00a0cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib63","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1128\/iai.59.9.3287-3290.1991","article-title":"Role of beta interferon in resistance to Toxoplasma gondii infection","volume":"59","author":"Orellana","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2020.01.099_bib64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00277-014-2183-0","article-title":"Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge","volume":"94","author":"Palandri","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.celrep.2020.01.099_bib65","first-page":"1807","article-title":"Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS","volume":"130","author":"Peng","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2020.01.099_bib66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib67","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.4049\/jimmunol.1501553","article-title":"Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice","volume":"195","author":"Prigge","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2020.01.099_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.177.1.22","article-title":"Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani","volume":"177","author":"Rosas","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib70","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1073\/pnas.1621447114","article-title":"Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis","volume":"114","author":"Rossi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2020.01.099_bib71","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/iai.57.10.3254-3256.1989","article-title":"Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages","volume":"57","author":"Schmitz","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2020.01.099_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/imm.12971","article-title":"Effects of type I interferons in malaria","volume":"155","author":"Sebina","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2020.01.099_bib73","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jir.2006.26.804","article-title":"Blocking monoclonal antibodies specific for mouse IFN-alpha\/beta receptor subunit 1 (IFNAR-1) from mice immunized by in\u00a0vivo hydrodynamic transfection","volume":"26","author":"Sheehan","year":"2006","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2020.01.099_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2017.00014","article-title":"Protozoan Parasites and Type I IFNs","volume":"8","author":"Silva-Barrios","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib94","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.1501046","article-title":"IL-17A-Producing gammadelta T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver","volume":"195","author":"Sheel","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.celrep.2020.01.099_bib75","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.celrep.2016.05.028","article-title":"Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia","volume":"15","author":"Silva-Barrios","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2020.01.099_bib76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2014.00296","article-title":"Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects","volume":"5","author":"Singh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib77","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cid\/ciu102","article-title":"Asymptomatic Leishmania infection: a new challenge for Leishmania control","volume":"58","author":"Singh","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib78","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S1473-3099(16)30140-2","article-title":"Elimination of visceral leishmaniasis on the Indian subcontinent","volume":"16","author":"Singh","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2020.01.099_bib79","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/eji.200635937","article-title":"Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T\u00a0cells","volume":"36","author":"St\u00e4ger","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2020.01.099_bib81","doi-asserted-by":"crossref","first-page":"e1000028","DOI":"10.1371\/journal.ppat.1000028","article-title":"Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis","volume":"4","author":"Stanley","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2020.01.099_bib82","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.140.11.3971","article-title":"Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis","volume":"140","author":"Stern","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib84","first-page":"646932","article-title":"Strategies to overcome antileishmanial drugs unresponsiveness","volume":"2014","author":"Sundar","year":"2014","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib85","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/icb.2012.7","article-title":"Modulation of T-cell function by type I interferon","volume":"90","author":"Tough","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2020.01.099_bib87","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib88","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib89","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib90","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.4049\/jimmunol.0903273","article-title":"Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites","volume":"184","author":"Xin","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2020.01.099_bib91","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2020.01.099_bib92","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.immuni.2016.10.001","article-title":"Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality","volume":"45","author":"Yu","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2020.01.099_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect. Dis."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:53:50Z","timestamp":1761908030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124720301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2211124720301339"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2020.01.099","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2020.01.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}